Skip to main content

Market Overview

62 Stocks Moving In Wednesday's Mid-Day Session

Share:

Gainers

  • Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) shares jumped 156.7% to $37.91 after the company reported Q3 results.
  • comScore, Inc. (NASDAQ: SCOR) climbed 24.9% to $3.11 following Q3 results.
  • Venator Materials PLC (NYSE: VNTR) gained 24.4% to $3.6450 after the company reported better-than-expected Q3 EPS and sales results.
  • Provention Bio, Inc. (NASDAQ: PRVB) climbed 22.5% to $8.42 after reporting Q3 results.
  • Inogen Inc (NASDAQ: INGN) rose 21% to $71.75 after the company reported better-than-expected Q3 EPS and sales results. The company issued FY20 sales guidance above analyst estimates.
  • SunOpta Inc. (NASDAQ: STKL) gained 20.8% to $2.4401 following Q3 results.
  • Boingo Wireless, Inc. (NASDAQ: WIFI) climbed 19.8% to $11.62 after reporting Q3 results.
  • Computer Programs and Systems, Inc. (NASDAQ: CPSI) shares gained 19.2% to $27.67 after reporting upbeat Q3 earnings.
  • Trupanion, Inc. (NASDAQ: TRUP) shares rose 18.3% to $28.43 after the company posted upbeat Q3 results and reported a $15 million buyback program.
  • PaySign, Inc. (NASDAQ: PAYS) gained 17.2% to $11.63 after the company reported better-than-expected Q3 EPS results.
  • Aquestive Therapeutics, Inc. (NASDAQ: AQST) climbed 17.1% to $4.9528 following Q3 results.
  • Office Depot, Inc. (NASDAQ: ODP) shares gained 17% to $2.5601 after the company reported better-than-expected Q3 EPS results. The company also reaffirmed FY19 sales guidance above analyst estimates.
  • Forty Seven, Inc. (NASDAQ: FTSV) shares rose 16.5% to $7.93.
  • Aircastle Limited (NYSE: AYR) climbed 16.4% to $32.11 after the company agreed to be acquired in a $2.4 billion deal.
  • Evolent Health, Inc. (NYSE: EVH) gained 16% to $9.27 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 sales guidance above analyst estimates.
  • Kimball Electronics, Inc. (NASDAQ: KE) climbed 15.2% to $17.67 following Q1 results.
  • Century Aluminum Company (NASDAQ: CENX) gained 14.8% to $8.09 despite reporting weak Q3 results. BMO Capital maintained an Outperform rating on the company's stock and raised the price target from $7 to $9.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) rose 14.7% to $2.7517 after climbing 34.83% on Tuesday.
  • Coty Inc. (NYSE: COTY) gained 14.1% to $13.07 after the company reported better-than-expected Q1 EPS results.
  • LendingClub Corporation (NYSE: LC) climbed 14% to $15.04 following Q3 results.
  • CymaBay Therapeutics, Inc. (NASDAQ: CBAY) gained 13.6% to $5.89 following Q3 results.
  • MBIA Inc. (NYSE: MBI) climbed 13.4% to $10.75 after reporting Q3 results.
  • NOW Inc. (NYSE: DNOW) climbed 12.5% to $12.49 following upbeat Q3 earnings.
  • Stage Stores, Inc. (NYSE: SSI) gained 12.3% to $2.93.
  • Purple Innovation, Inc. (NASDAQ: PRPL) jumped 11.2% to $8.61 following strong Q3 results.
  • Paysign Inc (NASDAQ: PAYS) rose 10.3% to $10.94 after the company reported better-than-expected Q3 EPS results.
  • HP Inc.. (NYSE: HPQ) shares rose 9.6% to $20.17 following a report that Xerox is considering buying out HP.
  • Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) rose 5.7% to $18.97 after the company reported better-than-expected Q3 EPS results.
  • CVS Health Corporation. (NYSE: CVS) shares rose 5% to $70.58 after the company reported upbeat earnings for its third quarter and raised its FY19 earnings guidance.

Check out these big penny stock gainers and losers

Losers

  • Fluidigm Corporation (NASDAQ: FLDM) shares tumbled 51.2% to $2.4950 after the company reported worse-than-expected Q3 sales results.
  • Plantronics, Inc. (NYSE: PLT) fell 40.6% to $23.42 after the company reported worse-than-expected Q2 EPS and sales results.
  • BlueLinx Holdings Inc. (NYSE: BXC) dropped 39.6% to $18.72 following Q3 results.
  • Vapotherm, Inc. (NASDAQ: VAPO) dipped 37.9% to $7.75 after the company posted downbeat Q3 sales and lowered FY19 sales guidance.
  • Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) dropped 31.8% to $19.88 after the company reported downbeat Q3 results. The P301 trial of SPN-810 to treat impulsive aggression in attention deficit hyperactivity disorder in patients 6-11 did not meet the primary endpoint, according toSupernus Pharmaceuticals.
  • NextCure, Inc. (NASDAQ: NXTC) dropped 28.1% to $66.31.
  • Neonode Inc. (NASDAQ: NEON) fell 26.6% to $1.68 following Q3 results.
  • Town Sports International Holdings, Inc. (NASDAQ: CLUB) dipped 23.6% to $1.59 following Q3 results.
  • ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) dipped 22.2% to $61.41 following Q3 results.
  • Radius Health, Inc. (NASDAQ: RDUS) dropped 20.5% to $22.34 after reporting Q3 results.
  • Sierra Wireless, Inc. (NASDAQ: SWIR) fell 20.3% to $8.99 after the company reported weaker-than-expected earnings for its third quarter and reported the purchase of M2M Group of companies in Australia.
  • Altice USA, Inc. (NYSE: ATUS) fell 20% to $25.09 after the company reported worse-than-expected Q3 EPS and sales results.
  • Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) dropped 19.9% to $2.7550 after the company reported worse-than-expected Q3 EPS and sales results.
  • Adesto Technologies Corporation (NASDAQ: IOTS) dipped 19.3% to $7.51 following weak Q3 sales.
  • ArQule, Inc. (NASDAQ: ARQL) dropped 18.5% to $7.93 after the company presented an abstract with early stage results of its reversible BTK inhibitor ARQ 531.
  • Camber Energy, Inc. (NYSE: CEI) dropped 18.3% to $2.0998.
  • GW Pharmaceuticals plc (NASDAQ: GWPH) shares fell 17.6% to $111.04 after the company reported Q3 earnings results.
  • HyreCar Inc. (NASDAQ: HYRE) dropped 16.6% to $2.11 following Q3 results.
  • Vonage Holdings Corp. (NYSE: VG) fell 16.6% to $8.39 after the company reported worse-than-expected Q3 EPS and sales results.
  • The Lovesac Company (NASDAQ: LOVE) tumbled 16.6% to $14.12.
  • OptimizeRx Corporation (NASDAQ: OPRX) fell 16.3% to $10.09 after the company reported worse-than-expected Q3 EPS and sales results.
  • WW International, Inc. (NASDAQ: WW) fell 15.7% to $31.64 after the company reported worse-than-expected Q3 sales results.
  • Cornerstone Building Brands, Inc. (NYSE: CNR) dropped 15.4% to $5.81 following downbeat quarterly sales.
  • KAR Auction Services, Inc. (NYSE: KAR) dipped 15.3% to $21.59 after the company reported worse-than-expected Q3 EPS results. The company also issued FY19 EPS guidance below analyst estimates.
  • Diamondback Energy Inc (NASDAQ: FANG) fell 15.2% to $76.57 after the company reported worse-than-expected Q3 sales results.
  • Acceleron Pharma Inc. (NASDAQ: XLRN) dipped 14.5% to $40.74 following downbeat Q3 results.
  • Nu Skin Enterprises, Inc. (NYSE: NUS) fell 14.4% to $39.69 after the company reported worse-than-expected Q3 sales results. The company also issued Q4 and FY19 EPS and sales guidance below analyst estimates.
  • The Hackett Group, Inc. (NASDAQ: HCKT) dropped 13.1% to $15.29 after reporting weak Q3 results.
  • Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares fell 11.6% to $28.26 after the company reported worse-than-expected Q3 EPS results.
  • Perion Network Ltd. (NASDAQ: PERI) shares fell 9.5% to $5.25 after the company reported Q3 results.
  • Intelsat S.A. (NYSE: I) shares fell 9.1% to $23.93.
  • Acadia Healthcare Company Inc (NASDAQ: ACHC) fell 5.3% to $29.72 after the company reported worse-than-expected Q3 EPS and sales results.
  • Match Group, Inc. (NASDAQ: MTCH) fell 5.2% to $65.19 after the company reported Q3 earnings results.
 

Related Articles (ACHC + AGRX)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com